GlassScriptPhysician profile
Ruth A Brandt
NPI 1548370455
$1,737.63
in general payments reported to CMS, 2019-2025
23 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $67.88 · 2021: $287 · 2022: $479 · 2023: $262 · 2024: $214 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $354.81 | 2019-2025 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $260.17 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $201.34 | 2019-2024 | Veozah |
| Sumitomo Pharma America, INC. | $119.03 | 2023-2024 | Gemtesa, Myfembree |
| Aspira Women'S Health INC | $89.83 | 2022-2025 | Ova1 |
| Daiichi Sankyo INC. | $88.34 | 2019-2024 | Injectafer |
| Pfizer INC. | $79.78 | 2022-2025 | |
| Amag Pharmaceuticals, INC. | $71.69 | 2019 | |
| Merck Sharp & Dohme LLC | $62.80 | 2022-2025 | Gardasil 9 |
| Channel Medsystems, INC. | $61.17 | 2025 | |
| Axonics, INC. | $57.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.16 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $42.21 | 2022-2023 | |
| Coopersurgical, INC. | $29.35 | 2024 | Endosee |
| Biohaven Pharmaceutical Holding Company LTD. | $29.01 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $23.21 | 2024 | Slynd |
| Myovant Sciences INC. | $20.49 | 2021 | |
| Organon LLC | $20.02 | 2025 | Nexplanon, Nuvaring |
| Medtronic, INC. | $19.84 | 2023 | Truclear |
| Becton, Dickinson and Company | $17.60 | 2023 | Bd Onclarity |
| Shield Therapeutics INC | $15.81 | 2024 | |
| Biogen, INC. | $14.98 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $14.01 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Brandt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.